Cresset Asset Management, LLC
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 1761013
Chicago, IL
Position in IOVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,347,088
+$97,333 QoQ
Shares Held
383,786
-16.2% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cresset Asset Management, LLC holds $83,905,083 across 42 Biotechnology names. IOVA ranks #9 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
739,191 | $38,630,121 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
259,397 | $16,764,828 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,860 | $3,509,804 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
13,633 | $2,577,318 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
86,063 | $2,130,919 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
72,435 | $2,028,904 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,537 | $1,960,187 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
|
11,860 | $1,478,349 |
All Filings in IOVA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,347,088 | 383,786 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,249,755 | 457,786 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $413,354 | 190,486 | Shares | Sole | 2026-01-22 | |
| 2025-06-30 | $327,269 | 190,273 | Shares | Sole | 2026-01-22 | |
| 2025-03-31 | $260,649 | 78,273 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $579,434 | 78,302 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $758,796 | 80,809 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $641,142 | 79,943 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,052,605 | 71,026 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $623,896 | 76,740 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $207,334 | 45,568 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $227,335 | 32,292 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $189,410 | 31,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $198,090 | 31,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $431,100 | 45,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $265,313 | 24,032 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $479,420 | 28,794 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $370,097 | 19,387 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $465,876 | 18,892 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $600,177 | 23,066 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $333,538 | 10,535 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||